A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT ⧉.
DaraEx plus is available from inno-train ⧉.
New Versions of the IFU for DaraEx plus and DaraEx are now available (release 2024/07/01).
EN ISO 13485:2016, issued May 09th, 2023
Certificate Directive 98/79/EC, issued May 20th, 2022
ISO 13485:2016 Certificate | Expiry date: 2026-05-22 | |
Directive 98/79/EC Certificate | Expiry date: 2025-05-26* |
*Please note: As of August 16th, 2022 imusyn has withdrawn the recombinant Blood Group Antigen (rBGA) Reagents from the scope of EC Certificate 0197/HL1381718-1. Our rBGA are available for Research Use Only (RUO).